Zinc oxide ointment recalled over current good manufacturing practice deviations
Blossom Pharmaceuticals is recalling 33000 containers of Globe Zinc Oxide Ointment USP over current good manufacturing practice deviations.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: Scored 2 because the record cites current good manufacturing practice deviations with no stated product defect or reported harm.
Plain-English summary
Globe Zinc Oxide Ointment USP, Zinc Oxide 20% Skin Protectant, net weight 2 oz (56.7 g), NDC 69396-086-02, distributed by Trifecta Pharmaceuticals USA of Ft. Lauderdale, Florida, is being recalled.
The reason given in the enforcement record is cGMP deviations.
The recall covers 33000 containers from lots A502404, expiry 2/27; A502405, expiry 2/27; and AS02502, expiry 2/28. Distribution was nationwide in the USA. The FDA has classified the action as Class II.
The record cites manufacturing practice deviations without describing a specific product defect, and states no injuries. Customers should follow the firm's instructions.
The recalled product
- Product
- ZINC OXIDE 20% (ZINC OXIDE)
- Brand
- ZINC OXIDE 20%
- Manufacturer
- Blossom Pharmaceuticals
- Category
- Drug — Skin protectant
- Affected units
- 33,000
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lot #: A502404
- Exp. Date 2/27
- A502405
- AS02502
- Exp. Date 2/28.
UPCs (1)
- 0040232454912
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 13 recalled by Blossom Pharmaceuticals under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 13 products in this recall →Related recalls
Same manufacturer · Blossom Pharmaceuticals
See all →- ModerateClotrimazole cream, 1 ounce size, recalled over good manufacturing practice deviations
FDA (Drugs) · 2025-12-10
- ModerateWound hydrogel recalled over current good manufacturing practice deviations
FDA (Drugs) · 2025-12-10
- ModerateDynashield Skin Protectant, 16 ounce size, recalled over manufacturing practice deviations
FDA (Drugs) · 2025-12-10
- ModerateWeCare zinc oxide ointment recalled over good manufacturing practice deviations
FDA (Drugs) · 2025-12-10
- ModerateLanashield Skin Barrier recalled over current good manufacturing practice deviations
FDA (Drugs) · 2025-12-10
Same hazard · cgmp deviation
See all →- SevereZicam Cold Remedy Nasal Swabs Recalled for Microbiological Testing Failures
FDA (Drugs) · 2026-09-02
- ModerateGolden State Medical Supply Recalls Carbamazepine Tablets Due to CGMP Deviations
FDA (Drugs) · 2026-08-26
- HighShoolin Pharma Recalls Tadalafil USP Due to CGMP Deviations
FDA (Drugs) · 2026-08-19
- ModerateSildenafil Citrate USP Recalled for CGMP Deviations Noted During FDA Inspection
FDA (Drugs) · 2026-08-19
- ModerateSildenafil Citrate Recall Due to CGMP Deviations
FDA (Drugs) · 2026-08-19